Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 1 ... losing virological control. The one-pill, once-daily formulation of efavirenz plus tenofovir and emtricitabine offers a particular advantage in this regard. Efavirenz also retains a ...
2009 NOV 16 ... Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) ...
2009 NOV 2 ... the strong growth in sales of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) and continued growth in sales of Truvada® ...
2009 SEP 28 ... AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg. Mylan's product ...
2009 SEP 28 ... been mainly studied with lamivudine, but it will be most effective with entecavir and tenofovir, which have a low risk of resistance," wrote G.V. Papatheodoridis and colleagues, ...
2009 OCT 5 ... do not conform to their laws. Using case-study examples, including the antiretroviral tenofovir disoproxil fumarate (TDF, or Viread), we demonstrate the importance of having outside ...
2009 NOV 9 ... and/or zidovudine + lamivudine + efavirenz or nevirapine; 41 of 338 (12.1%) had received tenofovir (TDF). The most common nucleoside reverse transcriptase inhibitor mutations observed ...
2009 OCT 5 ... concentration of more than 5000 copies per mL, and no baseline resistance to efavirenz, tenofovir, or emtricitabine. were randomly allocated by interactive voice response system in a 1:1 ...
2009 NOV 16 ... report. "We evaluated two long-acting reverse transcriptase inhibitors, tenofovir (TFV) and emtricitabine (FTC), by using a twice-weekly repeat challenge macaque model ...
2009 OCT 5 ... inhibitor and one thymidine analogue to atazanavir/ritonavir plus abacavir/lamivudine or tenofovir/emtricitabine. Adult HIV-infected patients on their first antiretroviral therapy (of at ...
2009 OCT 12 ... have been presented. According to recent research from Liverpool, the United Kingdom, "Tenofovir/emtricitabine (TDF/FTC) and abacavir/lamivudine (ABC/3TC) are widely used with ritonavir ...
2009 NOV 16 ... "In treatment-naive patients, a combination antiretroviral therapy (cART) containing tenofovir (TDF) and abacavir (ABC) with lamivudine leads to unacceptably high virological failure ...
2009 NOV 16 ... models or humans. We have prepared [F-18]FPMPA, a fluorine-18-radiolabeled analogue of tenofovir, to study antiretroviral tissue kinetics in vivo noninvasively and tested the imaging ...
2009 OCT 5 ... According to a study from the United States, "The antiviral drug tenofovir (TFV) is orally administered as the fumarate salt of its disoproxil prodrug (TFV ...
2009 SEP 28 ... syndrome drug, 9-®-[2-(phosphonomethoxy)propyl]adenine (®-PMPA, tenofovir), and six related antiviral acyclic nucleoside phosphonates using beta-CD as a chiral ...
2009 NOV 16 ... 53 (31.4%) patients were ART-naive, 46 (27.2%) were under ART without Lamivudine or tenofovir, and the remaining 70 (41.4%) were under ART including Lamivudine or...
2009 NOV 9 ... "934 was an open-label, randomized Phase III study of emtricitabine + tenofovir DF + efavirenz (FTC + TDF + EFV) compared with lamivudine + zidovudine + efavirenz (3TC ...
